SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 214 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $1,014,000 | -57.4% | 75,415 | -46.2% | 0.03% | -72.8% |
| Q2 2015 | $2,380,000 | -56.7% | 140,147 | -69.2% | 0.10% | -51.4% |
| Q1 2015 | $5,498,000 | +57.7% | 454,796 | +8.3% | 0.21% | +52.5% |
| Q4 2014 | $3,487,000 | -5.4% | 420,089 | -1.0% | 0.14% | -2.8% |
| Q3 2014 | $3,687,000 | +32.4% | 424,291 | +66.9% | 0.14% | +30.0% |
| Q2 2014 | $2,784,000 | +50.5% | 254,244 | +22.9% | 0.11% | +39.2% |
| Q1 2014 | $1,850,000 | – | 206,917 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |